Industry, FDA Coming Together On Risk Management For Marketed Devices

Representatives from the device industry and FDA are trying to establish common ground for how to assess and manage risk of potential safety or compliance issues that crop up for marketed devices.

Industry participants in a recently launched collaboration with FDA hope the effort will lead to more predictable and transparent postmarket enforcement actions.

Last fall, twenty-eight people from the medical device industry, FDA and the Association for the Advancement of Medical Instrumentation (AAMI) came together in a working group with the goal of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation